Summer School in Pharmaceutical Analysis (SSPA 2016) September 21-23, 2016 | Rimini, Italy
The Summer School in Pharmaceutical Analysis (SSPA) is organized by the Intradivisional group of Pharmaceutical Analysis, Division of Medicinal Chemistry, Italian Chemical Society (SCI) and sponsored by the European Federation for Medicinal Chemistry (EFMC)
SSPA is mainly addressed to researchers and PhD students focusing on the different aspects of analysis in drug discovery and development and in drug manufacturing. The course is open to a maximum of 80 students and is held in English.
SSPA 2016 will focus on “Advanced Analytical Methodologies for Biotechnological and Biological medicinal products”. SSPA2016 will start with a regulatory session, followed by four main sessions concerning:
- analytical methods in the discovery of Biotechnological and Biological medicinal products,
- analytical methods for the characterization of Biotechnological and Biological medicinal products,
- analytical methods in the pharmacokinetics of Biotechnological and Biological medicinal products,
- analytical methods in the manufacturing of Biotechnological and Biological medicinal products.
There will also be a special session dedicated to case reports discussed by R&D managers of companies operating in the field of Biotechnological and Biological medicinal products.
SSPA2016 participants can choose between two registration packages: an all inclusive registration or a basic registration, this latter not including accommodation.
- Luigi Colombo; Adjunct Professor at the University of Milan and Managing Director, Biopharma, Global Research & Development - Merck Serono SpA
- Carlo Emanuele Giartosio; Biosimilars and Early Phase Senior Manager; Analytical System Center of Expertise; Global Manufacturing & Supply – Merck Serono SpA
- Ira Krull; Professor Emeritus, Northeastern University’s Department of Chemistry and Chemical Biology, USA
- Drew N. Kelner, President, Colorado Biotechnology Consultants, USA; former Global Head of Analytical Sciences at Amgen.
- Juergen Kettenring, former Associate Director Teva Pharmaceuticals, Analytical Development
- Paola Minghetti; Professor of Pharmaceutical Technology and Legislation at the University of Milan, Italy
- Flavio Peroglio Associate Director Biopharma, Merck
- Riccardo Palmisano; President of Assobiotec and CEO of Molmed
- Koen Sandra; Research Institute for Chromatography, Belgium
Abstract submission deadline: June 30th
The complete programme, as well as information on registration and abstract submission can be found on the SSPA 2016 website: http://users2.unimi.it/SSPA/
Rare Diseases, Extraordinary Aspirations, October 13, 2016 - The Grand Connaught Rooms, Covent Garden, London
This meeting brings together experts from academia, industry and disease advocacy organisations working in the rare disease field to present their experiences and thoughts on tackling rare diseases through case studies and opinion pieces.
Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases which are classified as less than 200,000 total individual cases in the US and a rate of
Today, rare diseases and the drugs that treat them are sufficiently attractive that many companies and research institutes now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research.
This meeting brings together experts from academia, industry and disease advocacy organisations working in the rare disease field to present their experiences and thoughts on tackling rare diseases through case studies and opinion pieces. This promises to be an exciting and interesting meeting with in depth discussion of how the drug discovery and development community has approached rare disease research in the past and how this will evolve in the future to allow broader access to rare disease therapeutics. It will provide an excellent networking environment for anyone interested in this important research area.
£85 member rate
£135 non member rate
Web site: http://www.smr.org.uk/SMR/Meetings/20161013/Default.asp
2nd Anglo-Croatian Medicinal Symposium on Macrocycles: Medicinal Chemistry and Beyond-the-Rule-of-Five: October 17-18, 2016 at Fidelta, Zagreb, Croatia
The objective of this symposium is to promote scientific interaction between scientists with a shared interest in the field of Macrocycles. This area is responsible for a growing number of therapeutic approaches and development candidates, all of which go ‘beyond the rule-of–five’. As a researcher in this field, come along to hear about the latest advances and also share in some of the secrets of discovering therapeutic agents which go beyond Lipinski’s rules.
Presentations by young academics, poster session, and conference dinner.
Call for Papers
Are you a young researcher (postgraduate student, postdoctoral fellow or young academic, appointed since 2011)? Are you working in the synthesis, biological activity or medicinal chemistry of macrocycles?
If yes, then this is your chance to present your work at a major international symposium. The organising committee are looking for researchers to give poster presentations on their research at this symposium. The deadline is 11th August (call for posters and short talks).
Details of the conference dinner are to be confirmed. Attendance at the conference dinner is included in the registration fee.
Rooms at the 5* The Westin Zagreb in the heart of Zagreb are available at a special rate subject to availability. Details of the conference hotel may be found on the conference website.
MedChem 2016 - Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV: PET & Imaging: From Chemistry Lab to Clinical Applications, November 18, 2016 at Mont-Saint-Guibert, Belgium
The Medicinal Chemistry Divisions of the two Belgian Chemical Societies, the Société Royale de Chimie (SRC) and the Koninklijke Vlaamse Chemische Vereniging (KVCV), are pleased to announce their Annual Joint One-Day Symposium on Medicinal Chemistry: MEDCHEM 2016 - PET & Imaging: From Chemistry Lab to Clinical Applications.
Synopsis: The objective of the one-day symposium is to delve into the latest developments around Positron Emission Tomography (PET) and Imaging as invaluable non-invasive translational evaluation and diagnostic tools in drug discovery. Medicinal Chemistry now plays a critical role in the design, the synthesis and the characterization of suitable ligands with very specific properties. A sightseeing tour around state-of-the-art synthetic methodologies, tracers design and optimization principles, recent applications and perspectives in various therapeutic areas as well as selected case-studies will be presented.
Please note that the closing date for early-bird registration and submission of poster abstracts is 12th October 2016
News from the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)
The BMCS is pleased to announce the Symposium: "Plugging the Antibiotics Gap: a medicinal chemist's perspective" that will take place on 16th November 2016 at Manchester Science Park, Alderley Park, Manchester, UK.
Synopsis: Sustained under-investment in antimicrobials has led to a severe shortage of new drugs for treating infection. At a time when emerging antimicrobial resistance is decreasing the efficacy of existing treatments, it is more important than ever that we refresh the drug pipeline with new antimicrobials that act on new targets with novel modes of action.
Closing date for poster abstracts is 30th September
ISSUE SPONSORED BY
Founded in 2001, GalChimia has become the Spanish leader in synthetic organic chemistry. Our expert, dedicated team of chemists has found a productive outlet for their obsession with chemistry, providing services to clients worldwide.
EFMC ORGANISED EVENTS
EFMC SPONSORED EVENTS
EFMC ACCREDITED SCHOOL
EFMC SPONSORED SCHOOLS
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
Find us on social media